DOSAGE REDUCTION OF LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL DYSFUNCTION: EFFECTS ON ANTI-XA LEVELS AND CLINICAL OUTCOMES

被引：0
|
作者：
Hornung, Paul [1 ]
Khairoun, Meriem [1 ]
Dekker, Friedo W. [2 ]
Kaasjager, Karin A. H. [3 ]
Huisman, Albert [4 ]
Jakulj, Lily [5 ,6 ]
Bos, Willem Jan [7 ,8 ]
Rosendaai, Frits [2 ]
Verhaar, Marianne [1 ]
Ocak, Gurbey [1 ,2 ,7 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands
[2] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands
[3] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
[5] Univ Amsterdam, Dianet Dialysis Ctr, Med Ctr, Amsterdam, Netherlands
[6] Dept Nephrol, Amsterdam, Netherlands
[7] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands
[8] Leiden Univ, Dept Internal Med, Med Ctr, Leiden, Netherlands
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0810
引用
收藏
页码：1141 / 1141
页数：1
相关论文
共 50 条
  • [1] Dosage reduction of low weight heparin in patients with renal dysfunction: Effects on anti-Xa levels and clinical outcomes
    Hornung, Paul
    Khairoun, Meriem
    Dekker, Friedo W.
    Kaasjager, Karin A. H.
    Huisman, Albert
    Jakulj, Lily
    Bos, Willem Jan W.
    Rosendaal, Frits R.
    Verhaar, Marianne C.
    Ocak, Gurbey
    [J]. PLOS ONE, 2020, 15 (10):
  • [2] ANTI-XA POTENTIATING EFFECT OF LOW-MOLECULAR WEIGHT HEPARIN
    JUNKER, W
    HARENBERG, J
    FUSSI, F
    MATTES, K
    ZIMMERMANN, R
    WEBER, E
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 235 - 235
  • [3] Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer
    Kreuziger, Lisa Baumann
    Streiff, Michael
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 206 - 207
  • [4] Use of therapeutic dose low molecular weight heparin in patients with renal insufficiency: Analysis of anti-Xa levels and creatinine clearance.
    Lim, Wendy
    Sridhara, Manasa
    Wang, Luqi
    Kinnon, Krystyna
    Douketis, James
    Crowther, Mark
    [J]. BLOOD, 2006, 108 (11) : 265A - 265A
  • [5] Clinical Practice Patterns of Anti-Xa Monitoring During Low Molecular Weight Heparin Therapy
    Stutsky, Martha E.
    Reardon, David P.
    Lee, Alfred I.
    [J]. BLOOD, 2015, 126 (23)
  • [6] MONITORING AN ANTICOAGULATION USING A LOW-MOLECULAR WEIGHT HEPARIN (HBPM) - SIGNIFICANCE OF THE DOSAGE OF ANTI-XA ACTIVITY
    MASSONNETCASTEL, S
    PELISSIER, E
    TERRIER, E
    JAULMES, B
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1985, 43 (04) : 696 - 696
  • [7] Low molecular weight heparin is responsible for the anti-Xa activity of desmin 370
    Brieger, D
    Dawes, J
    [J]. THROMBOSIS AND HAEMOSTASIS, 1996, 75 (02) : 286 - 291
  • [8] Anti-Xa levels with low molecular weight heparin (Fraxiparin) and thrombolytic therapy for acute myocardial infarction
    deWinter, RJ
    Levi, M
    Chamuleau, SAJ
    Adams, R
    Buller, HR
    Prins, M
    Peters, RJG
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1168 - P1168
  • [9] Is monitoring anti-Xa levels necessary in pregnant women on therapeutic low molecular weight heparin (LMWH)?
    Temming, Lorene A.
    Young, Omar M.
    Stout, Molly J.
    Tuuli, Methodius G.
    Macones, George A.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S157 - S158
  • [10] Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin
    E McDonald
    F Landry
    C Rabbat
    C Boudreau
    M Crowther
    M Meade
    W Geerts
    D Cook
    [J]. Critical Care, 7 (Suppl 2):
12345